Document Preview Unavailable
Pharmacokinetics, pharmacodynamics, and safety of GS‐3583, a FLT3 agonist Fc fusion protein, from single‐ascending‐dose phase I study in healthy participants
Dauki, Anees M; Rajakumaraswamy, Nishanthan; Trowe, Torsten; Weng, Winnie; Lin, Kai‐Wen; et al. Clinical and Translational Science Vol. 17, Iss. 8, (Aug 1, 2024).You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library